US$ 29.47
glp-1 weight loss drug market news today Weight-loss drugs could boost US GDP by 1% in coming years, Goldman says The current range of weight-loss
Description
doi: 10.21037/apm.2019.10.01 2
A note on GLP-1 agonists for weight loss Though GLP-1 agonists can be beneficial for weight loss, its important to keep in mind that there is limited research on the long-term effects of these medications
"We want to reinforce that these drugs should be tried prior to GLP-1 agonists [for obesity treatment]," he said

8991 While DPP4 inhibitors have been extensively used in the treatment of type 2 diabetes mellitus (T2DM) for over a decade, their efficacy in T1DM remains uncertain
Future research should focus on understanding the long-term metabolic adaptations with these therapies, strategies for sustained weight loss, and long-term safety profile in various age groups
